Doximity Inc. Class A Common Stock (DOCS)

FairStock Score: 61/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses that earn high returns on capital, carry little debt, and sell at a sensible price. Doximity runs a digital network for medical professionals, and the balance sheet is fortress-like: debt-to-equity is 0.01, return on equity is 17.21%, and free cash flow is $297.0M, a 5.1% yield on the $5.8B market cap. The Altman Z-score of 21.82 and Piotroski F-score of 7/9 add comfort. But the price at the close on 2026-10-13 is $30.55. On FairStock's calculations, that is 36.37 times earnings, 6.00 times book, and 26.56 times EV/EBITDA. The Graham Number is $9.81, leaving a margin of safety of -211.42%, which is Graham's way of saying the stock is far from cheap. Growth was impressive over five years—FairStock calls it a Fast Grower, with 31.3% profit growth and 25.5% revenue growth—but the latest filed numbers show strain. In fiscal Q1 2027, the quarter ended 2026-06-30, revenue was $156.6M and net income was $24.3M, down from $53.3M in fiscal Q1 2026, the quarter ended 2025-06-30. For fiscal year 2026, ended 2026-03-31, revenue was $644.9M and net income was $196.1M. Profit growth is now negative on the trailing measure. This is a high-quality platform with cash generation and minimal debt, but the current price already assumes a lot. I would need a wider margin of safety and evidence that the profit drop is temporary before calling it attractive.

In plain English: Doximity runs an online network for doctors and other medical professionals, with news, research, and sponsored content from drugmakers. The business is profitable and produces cash, but its latest reported profit fell sharply from a year earlier. At the recent price of $30.55, the shares look expensive compared with the company's profits and accounting value, not cheap.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2027 10-Q (period ended 2026-06-30) · fiscal Q3 2026 10-Q (period ended 2025-12-31) · fiscal Q2 2026 10-Q (period ended 2025-09-30) · fiscal Q1 2026 10-Q (period ended 2025-06-30) · FY2026 10-K (period ended 2026-03-31) · FY2025 10-K (period ended 2025-03-31) · FY2024 10-K (period ended 2024-03-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer